600 patients66,869 observations120 daysLIVE

Patient P-01781

Synthetic patientNBL-101 · Day 111 · 45–54 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Stable
Nutritional resilience
Improving
Discontinuation risk
83%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 GI symptom burden −26% vs expectedDietary Support Protocol NP-02
  5. Day 48 Tolerance state changedUnstable → Improving
  6. Day 51 Trajectory diverged from predictionObserved response fell below the model's expected path.
  7. Day 51 SC-12 recommendedSupportive Compound SC-12
  8. Day 52 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 51.

Primary contributors, last 14 days
  • GI instability-9
  • Nutritional resilience+7
  • Toxicity+7
  • Treatment adherence+3

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: symptom burden −26%
  • Supportive Compound SC-12Day 51
    Declined by patient
LIFE OS recommendation
GI Support Protocol GI-04
85%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
51.9/100
improving · -6.8 vs previous 14 d
Toxicity
Blood
42.9/100
stable · +1.5 vs previous 14 d
Sleep quality
Wearable
21.9/100
improving · +9.4 vs previous 14 d
Energy level
Daily log
3.2/10
improving · +0.5 vs previous 14 d
Stress level
Daily log
6.7/10
improving · -0.5 vs previous 14 d
Steps
Wearable
3,719
improving · +377 vs previous 14 d
Adherence
Companion
51.4 %
stable · -1.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 31 from the failing basin, 56 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 88%
  • ME-01 Monitoring Escalation
    100% improved among 78 similar · onset 3 d · confidence 71%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 71%
Would not help
  • Keep fat low
    GI +6.6 next day on high-intake days · n 24
  • Keep alcohol low
    GI +5.5 next day on high-intake days · n 17
  • Keep spicy low
    GI +3.6 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +6.6detractor · 95%
  • Alcohol
    +5.5detractor · 95%
  • Spicy / capsaicin
    +3.6detractor · 76%
  • Insoluble fibre
    +3.2detractor · 57%
  • Simple carbohydrates
    -0.6no signal · 15%
  • Histamine load
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 38/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 70
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 51
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 52 and rising
    • WearableSleep 5.2 h, below personal baseline
  • Autonomic recovery 40
    • Wearable3,719 steps/day
    • WearableShort sleep window
  • Drug metabolism and exposure 20
    • BloodToxicity index 43
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 38/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
45 ms
Sleep
5.4 h
Steps
3,327
Resting HR
68 bpm
Daily log: GI score 52, nutritional resilience 46, adherence 51.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0138622%S1370
P-0135222%S2070
P-0175023%S1669
P-0169929%S04GI-04improved69
P-0175423%S1468
P-0150924%S1768
P-0187523%S1167
P-0181723%S1467
P-0187727%S01CR-01improved67
P-0162923%S1966
P-0171430%S14GI-04improved66
P-0185836%S14NP-02improved65